Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yusuke Kikukawa"'
Autor:
Yuumi Okuzono, Shuuichi Miyakawa, Tatsuo Itou, Masaki Sagara, Masashi Iwata, Kei Ishizuchi, Koji Sekiguchi, Haruhiko Motegi, Munenori Oyama, Dnyaneshwar Warude, Yusuke Kikukawa, Shigeaki Suzuki
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Myasthenia gravis (MG), primarily caused by acetylcholine receptor (AChR) autoantibodies, is a chronic autoimmune disorder causing severe muscle weakness and fatigability. In particular, seronegative MG constitutes 10%–15% of MG cases and presents
Externí odkaz:
https://doaj.org/article/349ba8e139934bc890e5dfe759296f04
Autor:
Zenichi Ikeda, Taku Kamei, Yusuke Sasaki, Matthew Reynolds, Nozomu Sakai, Masato Yoshikawa, Michiko Tawada, Nao Morishita, Douglas R. Dougan, Chien-Hung Chen, Irena Levin, Hua Zou, Masako Kuno, Naoto Arimura, Yusuke Kikukawa, Mitsuyo Kondo, Kimio Tohyama, Kenjiro Sato
Publikováno v:
Journal of Medicinal Chemistry. 66:6354-6371
Autor:
Pavlos Pissios, José Manuel Fernández-Real, Yusuke Kikukawa, Xiaojing Wei, Eleftheria Maratos-Flier, John M. Asara, Deepthi Prasad, Iphigenia Tzameli, Yoonjin Lee, José María Moreno-Navarrete, Shangyu Hong
Publikováno v:
© Nature Medicine, 2015, vol. 21, p. 887-894
Articles publicats (IdIBGi)
DUGiDocs – Universitat de Girona
instname
Articles publicats (IdIBGi)
DUGiDocs – Universitat de Girona
instname
Nicotinamide N-methyltransferase (Nnmt) methylates nicotinamide, a form of vitamin B3, to produce N(1)-methylnicotinamide (MNAM). Nnmt has emerged as a metabolic regulator in adipocytes, but its role in the liver, the tissue with the strongest Nnmt e
Publikováno v:
Journal of the Surface Finishing Society of Japan. 66:511-513
Autor:
Yasushi Fujitani, Chisei Ra, Daisuke Fujisawa, Tomomi Sasaki-Sakamoto, Satoshi Nunomura, Jun-ichi Kashiwakura, Koremasa Hayama, Kazumichi Kuroda, Hirohito Kita, Yoshimichi Okayama, Tadashi Terui, Yusuke Kikukawa
Publikováno v:
The Journal of allergy and clinical immunology. 134(3)
Background Wheal reactions to intradermally injected neuropeptides, such as substance P (SP) and vasoactive intestinal peptide, are significantly larger and longer lasting in patients with chronic urticaria (CU) than in nonatopic control (NC) subject